This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy CDMO. This report contains market size and forecasts of Cellular and Gene Therapy CDMO in global, including the following market information:
Global Cellular and Gene Therapy CDMO Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cellular and Gene Therapy CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cellular and Gene Therapy CDMO include Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec and Pharmaron, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cellular and Gene Therapy CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular and Gene Therapy CDMO Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, by Type, 2022 (%)
Cell Therapy
Viral Vectors
Plasmid
Global Cellular and Gene Therapy CDMO Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, by Application, 2022 (%)
Commercial
Academic Research
Others
Global Cellular and Gene Therapy CDMO Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular and Gene Therapy CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cellular and Gene Therapy CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent
Lonza
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cellular and Gene Therapy CDMO, market overview.
Chapter 2: Global Cellular and Gene Therapy CDMO market size in revenue.
Chapter 3: Detailed analysis of Cellular and Gene Therapy CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cellular and Gene Therapy CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cellular and Gene Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular and Gene Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular and Gene Therapy CDMO Overall Market Size
2.1 Global Cellular and Gene Therapy CDMO Market Size: 2022 VS 2030
2.2 Global Cellular and Gene Therapy CDMO Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular and Gene Therapy CDMO Players in Global Market
3.2 Top Global Cellular and Gene Therapy CDMO Companies Ranked by Revenue
3.3 Global Cellular and Gene Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cellular and Gene Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cellular and Gene Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cellular and Gene Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cellular and Gene Therapy CDMO Market Size Markets, 2022 & 2030
4.1.2 Cell Therapy
4.1.3 Viral Vectors
4.1.4 Plasmid
4.2 By Type - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2024-2030
4.2.3 By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2030
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2024-2030
5.2.3 By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2030
6.2 By Region - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2024-2030
6.2.3 By Region - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cellular and Gene Therapy CDMO Revenue, 2018-2030
6.3.2 US Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.3.3 Canada Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.3.4 Mexico Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cellular and Gene Therapy CDMO Revenue, 2018-2030
6.4.2 Germany Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.3 France Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.4 U.K. Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.5 Italy Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.6 Russia Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.7 Nordic Countries Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.4.8 Benelux Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cellular and Gene Therapy CDMO Revenue, 2018-2030
6.5.2 China Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.5.3 Japan Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.5.4 South Korea Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.5.5 Southeast Asia Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.5.6 India Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cellular and Gene Therapy CDMO Revenue, 2018-2030
6.6.2 Brazil Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.6.3 Argentina Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, 2018-2030
6.7.2 Turkey Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.7.3 Israel Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.7.4 Saudi Arabia Cellular and Gene Therapy CDMO Market Size, 2018-2030
6.7.5 UAE Cellular and Gene Therapy CDMO Market Size, 2018-2030
7 Cellular and Gene Therapy CDMO Companies Profiles
7.1 Catalent
7.1.1 Catalent Company Summary
7.1.2 Catalent Business Overview
7.1.3 Catalent Cellular and Gene Therapy CDMO Major Product Offerings
7.1.4 Catalent Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Catalent Key News & Latest Developments
7.2 Lonza
7.2.1 Lonza Company Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Cellular and Gene Therapy CDMO Major Product Offerings
7.2.4 Lonza Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 Lonza Key News & Latest Developments
7.3 Charles River
7.3.1 Charles River Company Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Cellular and Gene Therapy CDMO Major Product Offerings
7.3.4 Charles River Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 Charles River Key News & Latest Developments
7.4 The Discovery Labs
7.4.1 The Discovery Labs Company Summary
7.4.2 The Discovery Labs Business Overview
7.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Major Product Offerings
7.4.4 The Discovery Labs Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 The Discovery Labs Key News & Latest Developments
7.5 BIOCENTRIQ
7.5.1 BIOCENTRIQ Company Summary
7.5.2 BIOCENTRIQ Business Overview
7.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Major Product Offerings
7.5.4 BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 BIOCENTRIQ Key News & Latest Developments
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Major Product Offerings
7.6.4 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.7 Exothera
7.7.1 Exothera Company Summary
7.7.2 Exothera Business Overview
7.7.3 Exothera Cellular and Gene Therapy CDMO Major Product Offerings
7.7.4 Exothera Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Exothera Key News & Latest Developments
7.8 WuXi AppTec
7.8.1 WuXi AppTec Company Summary
7.8.2 WuXi AppTec Business Overview
7.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Major Product Offerings
7.8.4 WuXi AppTec Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 WuXi AppTec Key News & Latest Developments
7.9 Pharmaron
7.9.1 Pharmaron Company Summary
7.9.2 Pharmaron Business Overview
7.9.3 Pharmaron Cellular and Gene Therapy CDMO Major Product Offerings
7.9.4 Pharmaron Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Pharmaron Key News & Latest Developments
7.10 OBiO
7.10.1 OBiO Company Summary
7.10.2 OBiO Business Overview
7.10.3 OBiO Cellular and Gene Therapy CDMO Major Product Offerings
7.10.4 OBiO Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 OBiO Key News & Latest Developments
7.11 Cell Therapies
7.11.1 Cell Therapies Company Summary
7.11.2 Cell Therapies Business Overview
7.11.3 Cell Therapies Cellular and Gene Therapy CDMO Major Product Offerings
7.11.4 Cell Therapies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cell Therapies Key News & Latest Developments
7.12 AGC Biologics
7.12.1 AGC Biologics Company Summary
7.12.2 AGC Biologics Business Overview
7.12.3 AGC Biologics Cellular and Gene Therapy CDMO Major Product Offerings
7.12.4 AGC Biologics Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 AGC Biologics Key News & Latest Developments
7.13 Cytiva
7.13.1 Cytiva Company Summary
7.13.2 Cytiva Business Overview
7.13.3 Cytiva Cellular and Gene Therapy CDMO Major Product Offerings
7.13.4 Cytiva Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 Cytiva Key News & Latest Developments
7.14 Helixmith
7.14.1 Helixmith Company Summary
7.14.2 Helixmith Business Overview
7.14.3 Helixmith Cellular and Gene Therapy CDMO Major Product Offerings
7.14.4 Helixmith Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Helixmith Key News & Latest Developments
7.15 ThermoGenesis
7.15.1 ThermoGenesis Company Summary
7.15.2 ThermoGenesis Business Overview
7.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Major Product Offerings
7.15.4 ThermoGenesis Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 ThermoGenesis Key News & Latest Developments
7.16 Anemocyte
7.16.1 Anemocyte Company Summary
7.16.2 Anemocyte Business Overview
7.16.3 Anemocyte Cellular and Gene Therapy CDMO Major Product Offerings
7.16.4 Anemocyte Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 Anemocyte Key News & Latest Developments
7.17 Thermo Fisher Scientific
7.17.1 Thermo Fisher Scientific Company Summary
7.17.2 Thermo Fisher Scientific Business Overview
7.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Major Product Offerings
7.17.4 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Thermo Fisher Scientific Key News & Latest Developments
7.18 CBM
7.18.1 CBM Company Summary
7.18.2 CBM Business Overview
7.18.3 CBM Cellular and Gene Therapy CDMO Major Product Offerings
7.18.4 CBM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 CBM Key News & Latest Developments
7.19 Bio Elpida
7.19.1 Bio Elpida Company Summary
7.19.2 Bio Elpida Business Overview
7.19.3 Bio Elpida Cellular and Gene Therapy CDMO Major Product Offerings
7.19.4 Bio Elpida Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 Bio Elpida Key News & Latest Developments
7.20 Genezen
7.20.1 Genezen Company Summary
7.20.2 Genezen Business Overview
7.20.3 Genezen Cellular and Gene Therapy CDMO Major Product Offerings
7.20.4 Genezen Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 Genezen Key News & Latest Developments
7.21 CCRM
7.21.1 CCRM Company Summary
7.21.2 CCRM Business Overview
7.21.3 CCRM Cellular and Gene Therapy CDMO Major Product Offerings
7.21.4 CCRM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 CCRM Key News & Latest Developments
7.22 RoslinCT
7.22.1 RoslinCT Company Summary
7.22.2 RoslinCT Business Overview
7.22.3 RoslinCT Cellular and Gene Therapy CDMO Major Product Offerings
7.22.4 RoslinCT Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.22.5 RoslinCT Key News & Latest Developments
7.23 GenScript ProBio
7.23.1 GenScript ProBio Company Summary
7.23.2 GenScript ProBio Business Overview
7.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Major Product Offerings
7.23.4 GenScript ProBio Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.23.5 GenScript ProBio Key News & Latest Developments
7.24 Oxford BioMedica
7.24.1 Oxford BioMedica Company Summary
7.24.2 Oxford BioMedica Business Overview
7.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Major Product Offerings
7.24.4 Oxford BioMedica Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.24.5 Oxford BioMedica Key News & Latest Developments
7.25 Porton Pharma Solutions
7.25.1 Porton Pharma Solutions Company Summary
7.25.2 Porton Pharma Solutions Business Overview
7.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Major Product Offerings
7.25.4 Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.25.5 Porton Pharma Solutions Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cellular and Gene Therapy CDMO Market Opportunities & Trends in Global Market
Table 2. Cellular and Gene Therapy CDMO Market Drivers in Global Market
Table 3. Cellular and Gene Therapy CDMO Market Restraints in Global Market
Table 4. Key Players of Cellular and Gene Therapy CDMO in Global Market
Table 5. Top Cellular and Gene Therapy CDMO Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cellular and Gene Therapy CDMO Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cellular and Gene Therapy CDMO Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cellular and Gene Therapy CDMO Product Type
Table 9. List of Global Tier 1 Cellular and Gene Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cellular and Gene Therapy CDMO Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cellular and Gene Therapy CDMO Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 30. Catalent Company Summary
Table 31. Catalent Cellular and Gene Therapy CDMO Product Offerings
Table 32. Catalent Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 33. Catalent Key News & Latest Developments
Table 34. Lonza Company Summary
Table 35. Lonza Cellular and Gene Therapy CDMO Product Offerings
Table 36. Lonza Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 37. Lonza Key News & Latest Developments
Table 38. Charles River Company Summary
Table 39. Charles River Cellular and Gene Therapy CDMO Product Offerings
Table 40. Charles River Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Key News & Latest Developments
Table 42. The Discovery Labs Company Summary
Table 43. The Discovery Labs Cellular and Gene Therapy CDMO Product Offerings
Table 44. The Discovery Labs Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 45. The Discovery Labs Key News & Latest Developments
Table 46. BIOCENTRIQ Company Summary
Table 47. BIOCENTRIQ Cellular and Gene Therapy CDMO Product Offerings
Table 48. BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 49. BIOCENTRIQ Key News & Latest Developments
Table 50. FUJIFILM Diosynth Biotechnologies Company Summary
Table 51. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offerings
Table 52. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 53. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
Table 54. Exothera Company Summary
Table 55. Exothera Cellular and Gene Therapy CDMO Product Offerings
Table 56. Exothera Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 57. Exothera Key News & Latest Developments
Table 58. WuXi AppTec Company Summary
Table 59. WuXi AppTec Cellular and Gene Therapy CDMO Product Offerings
Table 60. WuXi AppTec Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 61. WuXi AppTec Key News & Latest Developments
Table 62. Pharmaron Company Summary
Table 63. Pharmaron Cellular and Gene Therapy CDMO Product Offerings
Table 64. Pharmaron Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 65. Pharmaron Key News & Latest Developments
Table 66. OBiO Company Summary
Table 67. OBiO Cellular and Gene Therapy CDMO Product Offerings
Table 68. OBiO Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 69. OBiO Key News & Latest Developments
Table 70. Cell Therapies Company Summary
Table 71. Cell Therapies Cellular and Gene Therapy CDMO Product Offerings
Table 72. Cell Therapies Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 73. Cell Therapies Key News & Latest Developments
Table 74. AGC Biologics Company Summary
Table 75. AGC Biologics Cellular and Gene Therapy CDMO Product Offerings
Table 76. AGC Biologics Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 77. AGC Biologics Key News & Latest Developments
Table 78. Cytiva Company Summary
Table 79. Cytiva Cellular and Gene Therapy CDMO Product Offerings
Table 80. Cytiva Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 81. Cytiva Key News & Latest Developments
Table 82. Helixmith Company Summary
Table 83. Helixmith Cellular and Gene Therapy CDMO Product Offerings
Table 84. Helixmith Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 85. Helixmith Key News & Latest Developments
Table 86. ThermoGenesis Company Summary
Table 87. ThermoGenesis Cellular and Gene Therapy CDMO Product Offerings
Table 88. ThermoGenesis Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 89. ThermoGenesis Key News & Latest Developments
Table 90. Anemocyte Company Summary
Table 91. Anemocyte Cellular and Gene Therapy CDMO Product Offerings
Table 92. Anemocyte Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 93. Anemocyte Key News & Latest Developments
Table 94. Thermo Fisher Scientific Company Summary
Table 95. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Offerings
Table 96. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 97. Thermo Fisher Scientific Key News & Latest Developments
Table 98. CBM Company Summary
Table 99. CBM Cellular and Gene Therapy CDMO Product Offerings
Table 100. CBM Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 101. CBM Key News & Latest Developments
Table 102. Bio Elpida Company Summary
Table 103. Bio Elpida Cellular and Gene Therapy CDMO Product Offerings
Table 104. Bio Elpida Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 105. Bio Elpida Key News & Latest Developments
Table 106. Genezen Company Summary
Table 107. Genezen Cellular and Gene Therapy CDMO Product Offerings
Table 108. Genezen Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 109. Genezen Key News & Latest Developments
Table 110. CCRM Company Summary
Table 111. CCRM Cellular and Gene Therapy CDMO Product Offerings
Table 112. CCRM Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 113. CCRM Key News & Latest Developments
Table 114. RoslinCT Company Summary
Table 115. RoslinCT Cellular and Gene Therapy CDMO Product Offerings
Table 116. RoslinCT Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 117. RoslinCT Key News & Latest Developments
Table 118. GenScript ProBio Company Summary
Table 119. GenScript ProBio Cellular and Gene Therapy CDMO Product Offerings
Table 120. GenScript ProBio Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 121. GenScript ProBio Key News & Latest Developments
Table 122. Oxford BioMedica Company Summary
Table 123. Oxford BioMedica Cellular and Gene Therapy CDMO Product Offerings
Table 124. Oxford BioMedica Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 125. Oxford BioMedica Key News & Latest Developments
Table 126. Porton Pharma Solutions Company Summary
Table 127. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Offerings
Table 128. Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 129. Porton Pharma Solutions Key News & Latest Developments
List of Figures
Figure 1. Cellular and Gene Therapy CDMO Segment by Type in 2022
Figure 2. Cellular and Gene Therapy CDMO Segment by Application in 2022
Figure 3. Global Cellular and Gene Therapy CDMO Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cellular and Gene Therapy CDMO Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cellular and Gene Therapy CDMO Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 8. By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 16. US Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 20. Germany Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 21. France Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 28. China Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 32. India Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 34. Brazil Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2030
Figure 37. Turkey Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 41. Catalent Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Lonza Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. The Discovery Labs Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Exothera Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. WuXi AppTec Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pharmaron Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. OBiO Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cell Therapies Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AGC Biologics Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cytiva Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Helixmith Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. ThermoGenesis Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Anemocyte Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. CBM Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Bio Elpida Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Genezen Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. CCRM Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. RoslinCT Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. GenScript ProBio Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Oxford BioMedica Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
